A Critical Study on International Trade of Medical Goods during Pandemic

The outbreak of the COVID-19 pandemic in 2019 exposed vulnerabilities in the global healthcare system, particularly regarding the international trade of medical goods worldwide. In 2020 International Trade fell suddenly but in 2021 get recovered sharply, however, the total trade flow of the world is above the pre-pandemic level. The COVID-19 pandemic altered trade patterns in a single year to an extent comparable to changes that would normally take four to five years. The variety of trade effects and shifts in trade flows among products, suppliers, and destinations point to high levels of uncertainty and adjustment costs. These factors also suggest that there are more incentives for businesses, governments, and consumers to implement new risk-reduction measures or to step up already-existing ones. The paper evaluates: 1. The impact of the pandemic on global trade flows concerning medical goods. 2. Analyses the role played by the World Trade Organizations in mitigating the challenges and ensuring the accessibility and affordability of medical supplies. 3. It also discusses lessons learned and proposes recommendations to enhance the resilience and effectiveness of international trade in medical goods in future health crises. This critical study aims to analyze the impact of the pandemic on International Trade, India’s trade at the global level, and potential avenues for improvement. Examining the interplay between supply chains, trade policies, and healthcare needs, the study explores the complexities faced by nations in ensuring access to essential medical supplies.